A plan to expand access to the drug treatment is hung up on fears of a black market, despite bipartisan support.
Related posts:
China admits its vaccines aren’t very good
Biden to expand vaccine requirements to frontline health workers
Texas ban spotlights Democrats’ generational divide on abortion and trans issues
Tensions mount between CDC and Biden health team over boosters
Philadelphia to end mask mandate, days after reinstating it
‘We’ve waited long enough’: DeSantis sues Biden administration over drug program
VA plans to offer abortion services to certain veterans and beneficiaries
White House launch of Operation Warp Speed 2.0 dragged down by funding problems and pandemic fatigue
Sanders goes big in new health package
‘A trapdoor wherever you step’: Why people are losing Medicaid in Arkansas
FDA recommends updated target for fall Covid boosters
‘His best friend died’: A GOP lawmaker takes on the cartels
